Prospective analysis of nosocomial infections in a burn care unit, Turkey

Indian Journal of Medical Research

Volumn 130, Issue 6, 2009, Pages 758-764

  Oncul, O ^a   Ulkur, E ^b   Acar, A ^b   Turhan, V ^a   Yeniz, E ^c   Karacaer, Z ^a   Yildiz, F ^b  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b Uskudar Istanbul ^*  (Turkey)

^c Sarikamis Army District Hospital Turkey   (Turkey)

Author keywords

Antibacterial resistance; Burn; Nosocomial infection

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; MEROPENEM; MOXIFLOXACIN; NETILMICIN; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; TETRACYCLINE; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; BURN; CHILD; COMORBIDITY; CONTROLLED STUDY; DRUG USE; FEMALE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RATE; INFECTIOUS PNEUMONIA; INVASIVE PROCEDURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; STAPHYLOCOCCUS AUREUS; TURKEY (REPUBLIC); URINARY TRACT INFECTION; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BURN UNITS; BURNS; CHILD; CROSS INFECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TURKEY; WOUND INFECTION; YOUNG ADULT;

EID: 74349086347     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lari AR, Alaghehbandan R. Nosocomial infections in an Iranian burn care center. Burns 2000; 26:737-40.
2. Falk PS, Winnike J, Woodmansee C, Desai M, Mayhall CG. Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol 2000; 21:575-82.
3. Roberts SA, Findlay R, Lang SD. Investigation of an outbreak of multi-drug resistant Acinetobacter baumannii in an intensive care burns unit. J Hosp Infect 2001; 48:228-32.
4. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992-June 2002, issued August 2002. Am J Infect Control 2002; 30:458-75.
5. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. In: Olmsted RN, editor. APIC infection control and applied epidemiology: Principles and practice. St. Louis: Mosby; 1996. p. A1-20.
6. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16:128-40.
7. Pruitt BA Jr, McManus AT, Kim SH, Goodwin CW. Burn wound infections: Current status. World J Surg 1998; 22:135-45.
8. Tanaka Y, Shimizu M, Hirabayashi H. Acute physiology, age, and chronic health evaluation (APACHE) III score is an alternative efficient predictor of mortality in burn patients. Burns 2007; 33:316-20.
9. Kumar P. Prophylactic antibiotics in burns. Burns 2006; 32:655-6.
10. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132:391-402.
11. Pronovost P, Needham D, Berenholtz S, Sinopoli D, Chu H, Cosgrove S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355:2725-32.
12. Hori S. Hospital infection control measures for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Nippon Rinsho 2002; 60:2144-9.
13. Evans RS, Lloyd JF, Abouzelof RH, Taylor CW, Anderson VR, Samore MH. System-wide surveillance for clinical encounters by patients previously identified with MRSA and VRE. Stud Health Technol Inform 2004; 107:212-6.
14. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Approved standard-Eighth edition. NCCLS Document M2-A8, Wayne PA.: NCCLS; 2003.
15. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 17th Informational Supplement. M100-S17, vol. 27, no. 1. Wayne, PA: 2007.
16. Falagas ME, Kasiakou SK. Correct use of the term 'pan-drug- resistant' (PDR) Gram-negative bacteria. Clin Microbiol Infect 2005; 11:1049-50.
17. Derksen S, Keselman HJ. Backward, forward and stepwise automated subset selection algorithms: frequency of obtaining authentic and noise variables. Br J Math Stat Psychol 1992; 45:265-82.
18. Taylor GD, Kibsey P, Kirkland T, Burroughs E, Tredget E. Predominance of staphylococcal organisms in infections occurring in a burns intensive care unit. Burns 1992; 18:332-5.
19. Wurtz R, Karajovic M, Dacumos E, Jovanovic B, Hanumadass M. Nosocomial infections in a burn intensive care unit. Burns 1995; 21:181-4.
20. Santucci SG, Gobara S, Santos CR, Fontana C, Levin AS. Infections in a burn intensive care unit: experience of seven years. J Hosp Infect 2003; 53:6-13.
21. Ekrami A, Kalantar E. Bacterial infections in burn patients at a burn hospital in Iran. Indian J Med Res 2007; 126:541-4.
22. Ozkurt Z, Ertek M, Erol S, Altoparlak U, Akcay MN. The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit. Burns 2005; 31:870-3.
23. Oncul O, Yuksel F, Altunay H, Acikel C, Celikoz B, Cavuslu S. The evaluation of nosocomial infection during 1-year-period in the burn unit of a training hospital in Istanbul, Turkey. Burns 2002; 28:738-44.
24. Mozingo DW, McManus AT, Kim SH, Pruitt BA Jr. Incidence of bacteremia after burn wound manipulation in the early postburn period. J Trauma 1997; 42:1006-11.
25. Ugburo AO, Atoyebi OA, Oyeneyin JO, Sowemimo GO. An evaluation of the role of systemic antibiotic prophylaxis in the control of burn wound infection at the Lagos University Teaching Hospital. Burns 2004; 30:43-8.
26. Maybauer MO, Maybauer DM, Traber LD, Westphal M, Enkhbaatar P, Morita N, et al. Gentamicin improves hemodynamics in ovine septic shock after smoke inhalation injury. Shock 2005; 24:226-31.